JAGX
Jaguar Animal Health Inc
NASDAQ: JAGX · HEALTHCARE · BIOTECHNOLOGY
$6.96
+2993.33% today
Updated 2026-04-30
Market cap
$3.65M
P/E ratio
—
P/S ratio
0.32x
EPS (TTM)
$-22.97
Dividend yield
—
52W range
$0 – $13
Volume
0.6M
WallStSmart proprietary scores
30
out of 100
Grade: F
Strong Sell
Investment rating
2.7
Growth
F5.0
Quality
C+2.5
Profitability
F6.7
Valuation
B—/9
Piotroski F-Score
—
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →202 stocks currently score above 75
Price targets
Analyst target
$7.50
+7.76%
12-Month target
—
—
Intrinsic (DCF)
$5.28
Margin of safety
+88.50%
Price chart
X-Ray snapshot
Strengths
+ 88.50% below intrinsic value
Risks
- Thin margins at 0.00%
- Negative free cash flow $-5.57M
- Revenue declining -7.80% QoQ
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $11.96M | $9.76M | $11.69M | $11.51M | $11.51M |
| Net income | $-47.45M | $-41.30M | $-38.49M | $-53.58M | $-23.20M |
| EPS | — | — | — | — | $-22.97 |
| Free cash flow | $-34.78M | $-33.24M | $-29.61M | $5.77M | $-5.57M |
| Profit margin | -396.91% | -423.11% | -329.30% | -465.42% | — |
Peer comparison
Smart narrative
Jaguar Animal Health Inc trades at $6.96. Our Smart Value Score of 30/100 indicates the stock is weak. TTM revenue stands at $11.51M. Our DCF model estimates intrinsic value at $5.28.
Frequently asked questions
What is Jaguar Animal Health Inc's stock price?
Jaguar Animal Health Inc (JAGX) trades at $6.96.
Is Jaguar Animal Health Inc overvalued?
Smart Value Score 30/100 (Grade F, Strong Sell). DCF value $5.28.
What is the price target of Jaguar Animal Health Inc (JAGX)?
The analyst target price is $7.50, representing +7.8% upside from the current price of $6.96.
What is the intrinsic value of Jaguar Animal Health Inc (JAGX)?
Based on our DCF model, intrinsic value is $5.28, a +88.5% margin of safety versus $6.96.
What is Jaguar Animal Health Inc's revenue?
TTM revenue is $11.51M.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio0.32x
ROE-411.60%
Beta0.29
50D MA$0.50
200D MA$1.35
Shares out0.01B
Float0.01B
Short ratio—
Avg volume0.6M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—